European mistletoe Viscum album L.
Also called: mistletoe, Viscum album
European mistletoe (Viscum album) is a semiparasitic plant that grows on trees such as apple, oak, pine and elm. Most research uses injected extracts given in cancer care; oral products, sold as dietary supplements, are a different exposure.
- Category
- Botanical
- Part used
- Plant extracts, mostly given by subcutaneous injection in studies; oral supplement products
- Strongest evidence
- B Some positive trials
- Native range
- Native range (POWO): Europe to Lebanon and Nepal, NE. Algeria
- Reviewed
- 2026-10-30
Class 1 Well studied in people. A 2008 Cochrane review included 21 RCTs (3,484 randomized cancer patients) of mistletoe extracts alone or added to chemotherapy or radiotherapy; its summary describes injection-site reactions, so the count concerns injected extracts, not oral products. [2]
Fact-checked 2026-10-30 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
CSeveral areas, whole body or blood1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Survival in people with cancer (extracts alone or added to chemotherapy or radiotherapy) | C | A 2008 Cochrane review of 21 RCTs (3,484 patients) found the evidence on survival weak: 6 of 13 survival trials showed some benefit, but none was of high methodological quality. [2] |
| Quality of life during chemotherapy | B | The 2008 Cochrane review of 21 RCTs found some evidence of better quality-of-life measures during chemotherapy for breast cancer, from 2 higher-quality trials; the authors said these results need replication. [2] |
| Survival and quality of life in advanced pancreatic cancer (MISTRAL trial) | X | In a double-blind RCT in advanced pancreatic cancer (143 extract, 147 placebo, added to standard care), extract injected subcutaneously three times weekly for nine months did not improve overall survival (median 7.8 vs 8.3 months) or global quality of life. [3] |
| Oral use | C | NCCIH states most studies used injected extract given by a health care provider and very little research has examined oral use. [4] |
Main constituents: Mistletoe lectins (ML-1, ML-2, ML-3), viscotoxins and polysaccharides, thought to contribute to its effects; most research focuses on the lectins [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Extracts are usually given by subcutaneous injection, often 2 to 3 times a week; oral, intrapleural, intratumoral and intravenous routes have also been described. [1]
- MISTRAL: mistletoe extract or placebo injected subcutaneously three times a week for nine months. [3]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Score EABCDEA: well known causeE: unlikely cause
LiverTox likelihood score E: mistletoe is unlikely a cause of clinically apparent liver injury, though it can cause cardiac and neurologic toxicity …
Details and sources - Pregnancy and breastfeedingNCCIH: European mistletoe is probably unsafe during pregnancy; little is known about its safety during breastfeeding.
1 statement in the profile.
Details and sources - Interactions with medicinesNothing found
No published information found in the sources checked.
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notificationsNone on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- NCCIH: 'European mistletoe berries and leaves can cause serious harmful effects when taken orally.' [4]
- NCI: mistletoe plants and berries are considered poisonous to humans, but few serious side effects have been associated with use of mistletoe extracts. [1]
- LiverTox: side effects of European mistletoe can include gastrointestinal discomfort, nausea, vomiting, chills, fever, pruritus, headache and fatigue; mistletoe can cause cardiac and neurologic toxicity at high doses. Likelihood score E (unlikely cause of clinically apparent liver injury). [5]
- Injections may cause soreness and inflammation at the injection site, headache, fever and chills; a few severe allergic reactions have been reported. [4]
- In MISTRAL, local skin reactions at injection sites occurred in 66% on extract vs 1% on placebo; other adverse events were similar in number, severity and outcome. [3]
- NCCIH: probably unsafe during pregnancy; little is known about safety during breastfeeding. [4]
Identity, quality and standardization
Regulatory status
- US: NCI states mistletoe extracts are not sold as drugs in the United States and are not approved for use in cancer; Viscum album is listed in the Homeopathic Pharmacopoeia of the United States. [1]
- US: NCCIH states the FDA has not approved European mistletoe as a treatment for cancer or any other medical condition. In Europe, injected extracts are sold as prescription drugs; it may also be taken orally as a dietary supplement. [4]
- LiverTox: European mistletoe is not approved for any condition in the US, where products are sold as dietary supplements; some are approved in Canada and the EU. [5]
- US: No NDI notification naming European mistletoe (Viscum album) was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [7]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
US status
What FDA's published records show. FDA does not approve dietary supplements.
- No NDI notification naming European mistletoe (Viscum album) was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P2]
- NCI: mistletoe extracts are not sold as drugs in the United States; Viscum album is listed in the Homeopathic Pharmacopoeia of the United States. [P1]
- NCCIH: the FDA has not approved European mistletoe as a treatment for cancer or any other medical condition; it may also be taken orally as a dietary supplement. [P8]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- LiverTox likelihood score E: mistletoe is unlikely a cause of clinically apparent liver injury, though it can cause cardiac and neurologic toxicity at high doses (chapter last updated July 25, 2022). In the rare reported cases, patients were also exposed to other potentially hepatotoxic herbs (skullcap, kudzu). [P5]
Interactions with medicines
- No published information found in the sources checked.
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test or examination of each dietary-ingredient component — US cGMP rule for dietary supplements: at least one appropriate test or examination must verify the identity of any component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)); exemption only through a petition FDA grants (111.75(a)(1)(ii)). [P6]
Supply and conservation
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- NCCIH: European mistletoe is probably unsafe during pregnancy; little is known about its safety during breastfeeding. [P8]
Sources for this profile
- National Cancer Institute. Mistletoe Extracts (PDQ), Health Professional Version (updated 11/06/2024), 2024-11-06. cancer.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications (list data last updated 2026-07-23; retrieved October 29, 2026), 2026-10-29. monographs.iarc.who.int
- National Toxicology Program. Technical Reports (list retrieved October 29, 2026), 2026-10-29. ntp.niehs.nih.gov
- NIH LiverTox (NIDDK). Mistletoe (Last Update: July 25, 2022), 2022-07-25. ncbi.nlm.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of October 23, 2026), 2026-10-23. ecfr.gov
- GBIF species API: IUCN Red List category for Viscum album L. (usageKey 2889828), 2026-10-29. api.gbif.org
- NCCIH. European Mistletoe (Last Updated: November 2024), 2024-11. nccih.nih.gov
Sources
- National Cancer Institute. Mistletoe Extracts (PDQ), Health Professional Version (updated 11/06/2024), 2024-11-06. cancer.gov
- Horneber MA, Bueschel G, Huber R, Linde K, Rostock M. Mistletoe therapy in oncology. Cochrane Database Syst Rev 2008;(2):CD003297 (PMID 18425885), 2008-04-16. pubmed.ncbi.nlm.nih.gov
- Wode K, Kienle GS, Björ O, et al. Mistletoe extract in patients with advanced pancreatic cancer: a double-blind, randomized, placebo-controlled trial (MISTRAL). Dtsch Arztebl Int 2024;121(11):347-354 (PMID 38915151), 2024-05-31. pubmed.ncbi.nlm.nih.gov
- NCCIH. European Mistletoe (Last Updated: November 2024), 2024-11. nccih.nih.gov
- NIH LiverTox (NIDDK). Mistletoe (Last Update: July 25, 2022), 2022-07-25. ncbi.nlm.nih.gov
- Loef M, Walach H. Survival of cancer patients treated with non-fermented mistletoe extract: a systematic review and meta-analysis. Integr Cancer Ther 2022;21:15347354221133561 (PMID 36324298), 2022. pubmed.ncbi.nlm.nih.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- Plants of the World Online (Royal Botanic Gardens, Kew). Viscum album L. (retrieved October 29, 2026), 2026-10-29. powo.science.kew.org
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.